For MSI tumors, the loss of expression of mismatch repair proteins (MMR) by IHC has been shown to be a sensitive marker, although the latter may miss a small group of patients, namely those with Lynch syndrome [30]. The gene discussed is MRC1; the disease is Lynch syndrome.